| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 02/10/2004 | US6689916 Tolterodine and analogues thereof, as well as to novel intermediates |
| 02/10/2004 | US6689782 3-piperazinyl-2-diarylurea-quinazolinone derivatives; potentiators of antifungal agents |
| 02/10/2004 | US6689593 Generation of farnesol; culture genetically engineered microorganism in nutrient broth, ferment in nutrient broth and recover farnesol |
| 02/05/2004 | WO2004010992A1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 02/05/2004 | WO2004010931A2 Color-stable, low impurity tocopherol compositions and processes for preparing the same |
| 02/05/2004 | US20040024240 Process for preparing homophthalate derivatives |
| 02/05/2004 | US20040023893 Coumarin derivatives for treatment of vascular disorders, skin disorders or allergies |
| 02/05/2004 | US20040022856 Carriers for drug delivery |
| 02/05/2004 | DE10232595A1 Lichtschutzmittel Light stabilizers |
| 02/05/2004 | CA2493913A1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 02/04/2004 | EP1386946A1 4,7-dichlororhodamine dyes useful as molecular probes |
| 02/04/2004 | EP1386919A1 Remedies |
| 02/04/2004 | EP1386317A1 Optical data carrier that contains a cyanine dye as the light-absorbing compound in the information layer |
| 02/04/2004 | EP1334093A4 Method for preparing dl-alpha-tocopherol with high yield |
| 02/04/2004 | CN1473159A 4 alpha-arylepicateching synthesis |
| 02/04/2004 | CN1472207A Extracting method of polyphenol from lotus root |
| 02/04/2004 | CN1472206A Method for preparing ginkgo leaf extractive |
| 02/04/2004 | CN1137115C Process for extracting flavone from pomelo peel |
| 02/03/2004 | US6686468 For use in synthetic resins to obtain violet to blue tints; used in phototropic glasses |
| 02/03/2004 | US6686461 Triphosphate oligonucleotide modification reagents and uses thereof |
| 02/03/2004 | US6686386 Combating photoinduced or chronological ageing of skin with retenoic acid receptor agonist |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 02/03/2004 | US6686209 Reagents for detecting cannabinoids |
| 02/03/2004 | CA2355987C Bicyclic amide derivatives and their use as muscle relaxants |
| 01/29/2004 | WO2004009577A1 Heterodiamondoids |
| 01/29/2004 | WO2004009576A2 Manufacture of isoflavones |
| 01/29/2004 | WO2004009575A1 An extract of a typhae pollen and its manufacture and use |
| 01/29/2004 | WO2004009527A1 Materials and methods for treating hypercholesterolemia |
| 01/29/2004 | WO2004009035A2 Compositions and products containing enantiomeric equol, and methods for their making |
| 01/29/2004 | WO2004009015A2 Combination therapy for the treatment of obesity |
| 01/29/2004 | US20040019227 Aminoflavone compounds, compositions, and methods of use |
| 01/29/2004 | US20040019226 Process for producing high purity isoflavones |
| 01/29/2004 | US20040019072 Dimer-selective RXR modulators and methods for their use |
| 01/29/2004 | US20040018261 Extract of Typhae Pollen traditional Chinese medicine consisting of flavonoids as active components includes kaempferol, quercetin and isorhamnetin; for lowering blood lipid level, preventing arteriosclerosis, coagulation |
| 01/29/2004 | US20040018192 Integrin expression inhibitors |
| 01/29/2004 | CA2492906A1 Materials and methods for treating hypercholesterolemia |
| 01/29/2004 | CA2492857A1 Heterodiamondoids |
| 01/29/2004 | CA2492754A1 Compositions and products containing enantiomeric equol, and methods for their making |
| 01/29/2004 | CA2492225A1 Combination therapy for the treatment of obesity |
| 01/28/2004 | EP1384475A1 Liver funcion protecting or ameliorating agent |
| 01/28/2004 | EP1383763A2 Method for producing 2- -5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane |
| 01/28/2004 | EP1383756A1 Coumarin derivatives to be used as anticoagulants |
| 01/28/2004 | EP1383732A1 Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules |
| 01/28/2004 | EP1383731A1 Biaryl compounds as serine protease inhibitors |
| 01/28/2004 | EP1383492A1 Molecular conjugates for use in treatment of cancer |
| 01/28/2004 | EP1204714B1 Bi-or terthienyl substituted photochromic naphtho 2,1-b]pyran compounds |
| 01/28/2004 | CN1470510A Epi-nutgall catechin gallic acid ester monomer purifying process |
| 01/28/2004 | CN1136211C Process for production of alpha-tocopherol esters |
| 01/27/2004 | US6683709 Spirofluorenopyrans for ophthalmic applications |
| 01/27/2004 | US6683194 Tocopherol derivatives |
| 01/27/2004 | US6683164 Extracting flavonoid with solvent mixture of methyl acetate and water, centrifuging to separate isoquercetin from solid raffinate, diluting with water, distilling off methyl acetate, cooling to precipitate isoquercitin, separating, drying |
| 01/27/2004 | US6683111 Such as 2-ethoxy-3-(4-(2-xanthen-9-ylidene-ethoxy)-phenyl)-propionic acid; for treating conditions associated with peroxisome proliferator-activated receptors; treatment of diabetes/obesity |
| 01/27/2004 | US6683095 CDK inhibitors having 3-hydroxychromen-4-one structure |
| 01/27/2004 | US6683068 For therapy of tetracycline compound-responsive states, such as bacterial infections and neoplasms |
| 01/27/2004 | US6682782 Organic compound having an acetylene group, vacuum deposition polymerization thereof, deposited polymerized thin film, and electroluminescence device containing same |
| 01/22/2004 | WO2004007531A2 Activated checkpoint therapy and methods of use thereof |
| 01/22/2004 | WO2004007487A1 Crystalline forms |
| 01/22/2004 | WO2004007486A1 Maleate salts |
| 01/22/2004 | WO2004007485A1 Besylate salts |
| 01/22/2004 | WO2004007484A1 Fumarate salts |
| 01/22/2004 | WO2004007475A1 Flavonoid compounds as therapeutic antioxidants |
| 01/22/2004 | WO2004007428A1 Process for the preparation of phenylalanine enamide derivatives |
| 01/22/2004 | US20040014996 Catalyzing the esterification reaction with acetic acid or acetic anhydride, forming tocopherol acetate or vitamin E acetate; heat exchanging |
| 01/22/2004 | US20040014995 Chromene compounds |
| 01/22/2004 | US20040014994 Method for resolving chiral (2s) and (2r) chromanes |
| 01/22/2004 | US20040014804 Anticoagulants; hydrogenation the corresponding nitro compound; reduction |
| 01/22/2004 | US20040014721 Method for using tethered bis(polyhydroxyphenyls) and O-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 01/22/2004 | US20040014168 Solid support comprises bead having diameter of 400-600 mu m functionalized with a silicon-containing linker |
| 01/22/2004 | US20040014160 For high throughput inhibition screening assays; involving metabolism based drug interactions which are a result of inhibition of cytochrome P450 enzymes |
| 01/22/2004 | CA2492772A1 Activated checkpoint therapy and methods of use thereof |
| 01/22/2004 | CA2492441A1 Process for the preparation of phenylalanine enamide derivatives |
| 01/21/2004 | EP1382597A2 Steroid receptor modulator compounds and methods |
| 01/21/2004 | EP1382329A1 Compositions for photoprotection comprising a flavonoid |
| 01/21/2004 | EP1381382A2 Methods and compositions for the treatment of diseases of the eye |
| 01/21/2004 | EP1128826B1 Chromone enteric release formulation |
| 01/21/2004 | CN1469741A Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts |
| 01/21/2004 | CN1468859A Longbract cattail general flavone extractive and its prepn and use |
| 01/20/2004 | US6680390 Sunscreen agents |
| 01/20/2004 | US6680387 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| 01/20/2004 | US6680381 Recovery of isoflavones from soy molasses |
| 01/20/2004 | US6680332 Substituted 5-oxo-5,6,7,8-tetrahydro-4H-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of AMPA |
| 01/20/2004 | US6680183 Production of optically active 2-substituted tetrahydropyran-4-ones |
| 01/15/2004 | WO2004005917A1 Fluorescent probe |
| 01/15/2004 | WO2004005243A2 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives |
| 01/15/2004 | WO2004005233A1 Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof |
| 01/14/2004 | EP1380578A1 Process for producing nitrile compound |
| 01/14/2004 | EP1380304A2 Process for the improvement of spermatozoa fertilization activity |
| 01/14/2004 | EP1379529A2 Pyranocoumarin compounds as a novel pharmacophore with anti-tb activity |
| 01/14/2004 | CN1468228A 7-carboxy-flavone derivatives, preparation method and therapeutic use |
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1468106A Sugar absorption inhibitors and process for producing the same |
| 01/14/2004 | CN1134427C Process for preparing 3-isochromanome |
| 01/14/2004 | CN1134426C Method for preparing substituted benzodihydropyran derivative |
| 01/14/2004 | CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same |
| 01/14/2004 | CN1134256C Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration. |
| 01/14/2004 | CN1134255C Antineoplastic cocoa extracts, method for making and uses |
| 01/13/2004 | US6677371 4-oxybenzopyran derivative |
| 01/13/2004 | US6677338 Serotonin transport inhibitors |
| 01/13/2004 | US6677325 Steroid sulphatase inhibitors |
| 01/13/2004 | CA2076664C Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists |